+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azithromycin Market by Product Type, Dosage Form, Route Of Administration, Indication, End User, Sales Channel - Global Forecast to 2030- Product Image
Azithromycin Market by Product Type, Dosage Form, Route Of Administration, Indication, End User, Sales Channel - Global Forecast to 2030- Product Image
Sale

Azithromycin Market by Product Type, Dosage Form, Route Of Administration, Indication, End User, Sales Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082440
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The azithromycin market is evolving amid shifts in global healthcare, regulatory scrutiny, and pressures surrounding cost and supply chain resilience. Decision-makers navigating this landscape require forward-looking insights to sustain growth and ensure access to critical antimicrobial therapies.

Market Snapshot: Azithromycin Market Overview

The Azithromycin Market grew from USD 7.40 billion in 2024 to USD 7.83 billion in 2025. It is expected to continue growing at a CAGR of 5.72%, reaching USD 10.34 billion by 2030. Generating consistent interest from healthcare professionals, payers, and manufacturers, azithromycin retains a pivotal role in anti-infective portfolios due to its broad activity, safety profile, and versatility in addressing respiratory, gastrointestinal, skin, and sexually transmitted infections. Market momentum is shaped both by established therapeutic use and the rising importance of antibiotic stewardship, regulatory adaptation, and strategic supplier relationships.

Scope & Segmentation

This analysis offers a comprehensive breakdown of the azithromycin market landscape, segmentation, technology adoption, and geographic coverage. Core segment areas include:

  • Product Types: Branded, Generic
  • Dosage Forms: Capsule, Suspension, Tablet
  • Route of Administration: Intravenous, Oral
  • Indications: Gastrointestinal Infections including Travelers Diarrhea, Respiratory Infections (upper and lower), Chlamydia and Gonorrhea, Acute Bacterial Skin Structure and Soft Tissue Infections
  • End Users: Ambulatory Care, Clinics, Homecare, Hospitals
  • Sales Channels: Drug Store, Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and neighboring countries)
  • Leading Companies: Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd.

Technology adoption is evident in advanced manufacturing (continuous processing, quality by design), digital diagnostics, and stewardship platforms that enhance patient adherence and optimize supply.

Key Takeaways: Strategic Insights for Decision-Makers

  • Azithromycin continues to serve as a cornerstone for diverse infection management, supporting both acute care settings and outpatient regimens.
  • Healthcare providers and suppliers are responding to rising antibiotic resistance by aligning with stewardship initiatives and adjusting prescribing patterns.
  • Manufacturers face ongoing pressure to optimize cost structures, diversify supply chains, and accelerate time-to-market for differentiated formulations.
  • Technological innovations—including extended-release and targeted-delivery platforms—enhance patient adherence and product consistency while supporting therapeutic outcomes.
  • Service offerings that bundle drug therapy with diagnostics and remote support are strengthening competitive positioning in a maturing market.
  • Regional market entry requires agility to address local regulatory requirements, pricing controls, and healthcare infrastructure disparities.

Tariff Impact: 2025 US Supply Chain Developments

The introduction of 2025 US tariffs on imported azithromycin components raises manufacturing expenses and prompts US-based companies to evaluate domestic supplier options. These measures drive recalibration of procurement strategies among distributors and push healthcare providers to periodically review alternative therapies to manage costs. Companies are bolstering supply chain resilience through buffer inventories, diversified sourcing, and greater investment in local production capabilities. Stakeholders implementing these mitigation strategies can maintain supply continuity and competitive positioning amid shifting cost dynamics.

Methodology & Data Sources

This report integrates primary and secondary data, combining peer-reviewed literature, regulatory filings, patent databases, and interviews with subject matter experts across clinical, pharmacy, procurement, and payer domains. Quantitative and qualitative insights are strengthened by data triangulation, ensuring a rigorous foundation for segmentation and trend analysis.

Why This Report Matters

  • Delivers actionable insights for strategic planning and risk mitigation in a complex regulatory and supply chain environment.
  • Supports informed decision-making by highlighting evolving market drivers, technology trends, and regional variations that affect azithromycin access and adoption.
  • Equips senior leaders with the knowledge needed to adapt to cost, compliance, and market entry challenges, maximizing both near-term and long-term value.

Conclusion

With shifting regulatory pressures, maturing supply chains, and ongoing clinical demands, the azithromycin market demands agile, data-driven strategies. This report positions industry stakeholders for sustained growth and effective response to emerging developments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Azithromycin Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Azithromycin Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Suspension
9.4. Tablet
10. Azithromycin Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Azithromycin Market, by Indication
11.1. Introduction
11.2. Gastrointestinal Infections
11.2.1. Travelers Diarrhea
11.3. Respiratory Infections
11.3.1. Lower Respiratory Infections
11.3.2. Upper Respiratory Infections
11.4. Sexually Transmitted Infections
11.4.1. Chlamydia Infections
11.4.2. Gonorrhea
11.5. Skin Infections
11.5.1. Acute Bacterial Skin Structure Infections
11.5.2. Soft Tissue Infections
12. Azithromycin Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.3. Clinics
12.4. Homecare
12.5. Hospitals
13. Azithromycin Market, by Sales Channel
13.1. Introduction
13.2. Drug Store
13.3. Hospital Pharmacy
13.4. Online Pharmacy
13.5. Retail Pharmacy
14. Americas Azithromycin Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Azithromycin Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Azithromycin Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Teva Pharmaceutical Industries Ltd.
17.3.3. Sandoz International GmbH
17.3.4. Cipla Ltd.
17.3.5. Dr. Reddy's Laboratories Ltd.
17.3.6. Viatris Inc.
17.3.7. Hikma Pharmaceuticals PLC
17.3.8. Zydus Lifesciences Ltd.
17.3.9. Lupin Limited
17.3.10. Sun Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AZITHROMYCIN MARKET MULTI-CURRENCY
FIGURE 2. AZITHROMYCIN MARKET MULTI-LANGUAGE
FIGURE 3. AZITHROMYCIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AZITHROMYCIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. AZITHROMYCIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AZITHROMYCIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AZITHROMYCIN MARKET SIZE, BY TRAVELERS DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 64. CANADA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 66. CANADA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 69. CANADA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 70. CANADA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 71. CANADA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 72. CANADA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. MEXICO AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. GERMANY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 127. GERMANY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. GERMANY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. FRANCE AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. FRANCE AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. ITALY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. ITALY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. ITALY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 160. ITALY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 161. ITALY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 162. ITALY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 163. ITALY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. ITALY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. SPAIN AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SPAIN AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. DENMARK AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. DENMARK AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. DENMARK AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. DENMARK AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. QATAR AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. QATAR AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. QATAR AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 230. QATAR AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 231. QATAR AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 232. QATAR AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 233. QATAR AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. QATAR AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. FINLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 237. FINLAND AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. FINLAND AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. FINLAND AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FINLAND AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. EGYPT AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 267. EGYPT AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. EGYPT AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 269. EGYPT AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 271. EGYPT AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. EGYPT AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. TURKEY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. TURKEY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. TURKEY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 281. TURKEY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. TURKEY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NORWAY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. NORWAY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 297. NORWAY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. NORWAY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 299. NORWAY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 301. NORWAY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. NORWAY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. POLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. POLAND AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 307. POLAND AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. POLAND AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 309. POLAND AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 310. POLAND AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 311. POLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 312. POLAND AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 313. POLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. POLAND AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 336. CHINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. CHINA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 338. CHINA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 339. CHINA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 340. CHINA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 341. CHINA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 342. CHINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 343. CHINA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 344. CHINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. CHINA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 346. INDIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. INDIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 348. INDIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 349. INDIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 350. INDIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 351. INDIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 352. INDIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2030 (USD MILLION)
TABLE 353. INDIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2030 (USD MILLION)
TABLE 354. INDIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2030 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Azithromycin market report include:
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Zydus Lifesciences Ltd.
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.34 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From
Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Image

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • 183 Pages
  • Global
From
Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Macrolide Antibiotics Market Report 2025 - Product Image

Macrolide Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Azithromycin Market

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.